Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MCTA will rise by +18.04% over the next 2 Weeks and hit $34.65 by Friday, February 13, 2026. In that time frame, MCTA's share price is expected to range between $30.20 and $39.28.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 13, 2026 | 29.26 | 34.82 | 40.06 |
| Feb 12, 2026 | 32.88 | 38.02 | 43.29 |
| Feb 11, 2026 | 29.03 | 34.68 | 39.69 |
| Feb 10, 2026 | 30.25 | 35.39 | 40.95 |
| Feb 9, 2026 | 27.85 | 33.22 | 38.81 |
| Feb 6, 2026 | 28.31 | 33.87 | 39.41 |
| Feb 5, 2026 | 31.75 | 37.07 | 42.54 |
| Feb 4, 2026 | 28.13 | 33.73 | 39.12 |
| Feb 3, 2026 | 29.13 | 34.44 | 40.32 |
| Feb 2, 2026 | 27.00 | 32.26 | 37.80 |
MCTA shares rose +6.75% in Friday, January 30, 2026's trading session, rising from a previous close of $29.36 to move at $29.36. The stock demonstrated notable intraday movement (see MCTA's key stats for a full breakdown), fluctuating between $29.36 and $29.36, a 0 trading range. While recent weeks have seen some volatility, MCTA has managed to secure a +30.52% gain over the past 2 weeks. The upward price movement was accompanied by remained steady trading volume, with approximately 4.25M shares changing hands, 0 fewer than the previous session. This amounted to $124.80M in total market activity.
Will MCTA Continue Its Upward Trend?
According to analyst ratings and projections for MCTA, Charming Medical Limited Class A Ordinary Shares shares are anticipated to increase by +26.72%, potentially reaching $40.06 per share by February 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for MCTA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 8 positive trading days within the past 30 sessions. Based on the MCTA stock forecast, now is a good time to buy MCTA stock because its current trading price is -15.70% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on MCTA covering social and institutional perspectives.
MCTA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MCTA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 78.41% to 80.19%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 78.41%, indicates significant medium-term strength. Insights into MCTA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Charming Medical Class A Ordinary Shares Short-Term Forecasts
MCTA Forecast For Next 5 Days
Our algorithm anticipates Charming Medical Class A Ordinary Shares (MCTA) stock could hit $25.78 by Jan 02, 2026. This represents a -12.19% fall from today's price, following a -5.96% change over the past five days.
MCTA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Charming Medical Limited Class A Ordinary Shares (MCTA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $25.57, which would mean a -12.89% decrease from the current price of $29.36. Projections for this period range from a high of $31.96 to a low of $16.09.
MCTA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Charming Medical Class A Ordinary Shares's price over the next three months point to a rise. MCTA stock is expected to peak at $502.25 on Mar 13, 2026 before potentially dipping to $0.00 on May 07, 2026. On average, MCTA is likely to trade around $82.62 in the coming 90 days.
Charming Medical Class A Ordinary Shares Stock Forecast 2025
Based on our predictive models, Charming Medical Class A Ordinary Shares (MCTA) is expected to trade between $0.00 and $502.25 throughout 2026. This would result in an average price of $53.98, potentially offering investors a +83.89% return from current levels.
Charming Medical Limited Class A Ordinary Shares Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Charming Medical Limited Class A Ordinary Shares (MCTA) is positioned to show a strong performance in December 2025. The price is predicted to move between $0.00 and $157.19, settling at an average of $58.60. This could translate to a +99.63% gain.
January 2026
Based on current market signals, Charming Medical Limited Class A Ordinary Shares is projected to trend january 2026. We forecast a trading range from $0.00 to $132.72, with a likely average price of $35.03. Investors could expect a potential return of +19.33%.
February 2026
Our predictive algorithms indicate Charming Medical Limited Class A Ordinary Shares stock may see a shift in February 2026. The expected range spans $0.00–$208.43, with an average target of $51.29. This represents a positive outlook and a possible gain of +74.72%.
March 2026
Analyzing established trends, Charming Medical Limited Class A Ordinary Shares looks set to move in March 2026. Projections place the stock between $0.00 and $502.25, averaging around $141.93. This suggests a +383.50% gain from current levels.
April 2026
Market indicators suggest Charming Medical Limited Class A Ordinary Shares could experience notable changes during April 2026. Prices could fluctuate within $0.00 to $239.78, with a midpoint forecast of $62.93. The stock might deliver a +114.38% gain.
May 2026
Forecasting for May 2026, models estimate that Charming Medical Limited Class A Ordinary Shares may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $116.77, averaging $15.06. This signals a cautious trajectory with potential returns around -48.70%.
June 2026
According to our latest forecast models, Charming Medical Limited Class A Ordinary Shares (MCTA) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.00 and $107.29, settling at an average of $26.10. This could translate to a -11.09% loss.
July 2026
Based on current market signals, Charming Medical Limited Class A Ordinary Shares is projected to trend july 2026. We forecast a trading range from $0.00 to $185.45, with a likely average price of $49.44. Investors could expect a potential return of +68.42%.
August 2026
Our predictive algorithms indicate Charming Medical Limited Class A Ordinary Shares stock may see a shift in August 2026. The expected range spans $0.00–$479.34, with an average target of $126.32. This represents a positive outlook and a possible gain of +330.32%.
September 2026
Analyzing established trends, Charming Medical Limited Class A Ordinary Shares looks set to move in September 2026. Projections place the stock between $0.00 and $221.42, averaging around $51.68. This suggests a +76.05% gain from current levels.
October 2026
Market indicators suggest Charming Medical Limited Class A Ordinary Shares could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $111.19, with a midpoint forecast of $16.75. The stock might deliver a -42.94% loss.
November 2026
Forecasting for November 2026, models estimate that Charming Medical Limited Class A Ordinary Shares may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $86.75, averaging $25.46. This signals a cautious trajectory with potential returns around -13.27%.
December 2026
According to our latest forecast models, Charming Medical Limited Class A Ordinary Shares (MCTA) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $99.74, settling at an average of $28.68. This could translate to a -2.30% loss.
MCTA's history of dividends and stock splits also plays a role in long-term investor confidence.